Patients' perceptions, attitudes, and experiences about the management of mild-to-moderate ulcerative colitis

被引:14
|
作者
Casellas, Francesc [1 ]
Vicens, Daniel Ginard [2 ]
Riestra Menendez, Sabino [3 ]
Alfaro Oliver, Noelia [4 ]
机构
[1] Hosp Univ Vall dHebron, Ciberehd, Crohn Colitis Care Unit, Barcelona 08035, Spain
[2] Hosp Univ Son Espases, Dept Gastroenterol, Palma de Mallorca 07120, Islas Baleares, Spain
[3] Hosp Univ Cent Asturias, Dept Gastroenterol, Oviedo 33006, Asturias, Spain
[4] Adv Res Tech Hlth Serv TAISS, Madrid 28034, Spain
关键词
Ulcerative colitis; Management of the disease; Treatment of the disease; Quality of life; Patient satisfaction; INFLAMMATORY-BOWEL-DISEASE; HEALTH-CARE; SATISFACTION; PERSPECTIVE; COPENHAGEN;
D O I
10.1016/j.crohns.2014.02.013
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: To establish the perceptions, attitudes, experiences, and satisfaction with clinical management of ulcerative colitis (UC) patients, particularly in aspects related to treatment. Methods: A qualitative, descriptive, exploratory study. A discussion group was performed in patients who were in remission according to the criteria of the Mayo index, who had never taken biologics or corticosteroids in the past year. They were selected by: course (mild/moderate), time since onset (under 5 years/5 to 9 years/10 years or more), follow-up area (primary care [PC]-hospital/PC-specialist care/hospital), treatment (yes/no), UC care unit (yes/no), belongs to patient associations (yes/no) and sex. A descriptive-interpretative content analysis was performed to detect emerging categories, providing them with an explanatory framework. Results: Diagnostic delay was detected due to lack of clinical suspicion from PC and delayed diagnostic tests. For follow-up, patients prefer care on demand, channeled through remote care, which helps to resolve questions, problems with treatment, or when a relapse occurs, minimizing visits to the hospital. They demand more information, both about UC and treatment. The expectations about treatments are limited, so they mainly requested efficacy and safety. Conclusion: The results suggest the importance of developing strategies to facilitate care on demand and remote care, and to investigate on effective and safe treatments to minimize the detriment to quality of life of patients. These strategies should guarantee fast care and, together with safe and effective treatments, optimize the management of UC patients. (C) 2014 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1097 / 1107
页数:11
相关论文
共 50 条
  • [21] Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial
    Lang, Alon
    Salomon, Nir
    Wu, Justin C. Y.
    Kopylov, Uri
    Lahat, Adi
    Har-Noy, Ofir
    Ching, Jessica Y. L.
    Cheong, Pui Kuan
    Avidan, Benjamin
    Gamus, Dorit
    Kaimakliotis, Ioannis
    Eliakim, Rami
    Ng, Siew C.
    Ben-Horin, Shomron
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (08) : 1444 - +
  • [22] Long-Term Clinical Outcomes and Factors Predictive of Relapse after 5-Aminosalicylate or Sulfasalazine Therapy in Patients with Mild-to-Moderate Ulcerative Colitis
    Lee, Hyun Jung
    Jung, Eun Suk
    Lee, Jin Ha
    Hong, Sung Pil
    Kim, Tae Il
    Kim, Won Ho
    Cheon, Jae Hee
    HEPATO-GASTROENTEROLOGY, 2012, 59 (117) : 1415 - 1420
  • [23] Mild-to-moderate ulcerative colitis: Your role in patient compliance and health care costs
    Tindall, William N.
    Boltri, John M.
    Wilhelm, Sheila M.
    JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (07): : S2 - S12
  • [24] eHealth: Individualization of Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis
    Pedersen, Natalia
    Thielsen, Peter
    Martinsen, Lars
    Bennedsen, Mette
    Haaber, Anne
    Langholz, Ebbe
    Vegh, Zsuzsanna
    Duricova, Dana
    Jess, Tine
    Bell, Sally
    Burisch, Johan
    Munkholm, Pia
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (12) : 2276 - 2285
  • [25] Safety, Efficacy, and Pharmacokinetics of Balsalazide in Pediatric Patients With Mild-to-Moderate Active Ulcerative Colitis: Results of a Randomized, Double-blind Study
    Quiros, J. Antonio
    Heyman, Melvin B.
    Pohl, John F.
    Attard, Thomas M.
    Pieniaszek, Henry J.
    Bortey, Enoch
    Walker, Kelli
    Forbes, William P.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2009, 49 (05) : 571 - 579
  • [26] Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus
    Al Awadhi, Sameer
    Alboraie, Mohamed
    Albaba, Emad Aldin
    Almutairdi, Abdulelah
    Alsaad, Monther
    Azzam, Nahla
    Barakat, Husam
    D'Amico, Ferdinando
    Danese, Silvio
    El Kady, Mohamed
    Ghoneim, Hossam
    Hamoudi, Waseem
    Jazzar, Ahmad
    Mosli, Mahmoud
    Shehab, Hany
    Sneineh, Awni Abu
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (21)
  • [27] Effects of Mediterranean Diet, Curcumin, and Resveratrol on Mild-to-Moderate Active Ulcerative Colitis: A Multicenter Randomized Clinical Trial
    Dogan, Ozge Erol
    Celik, Kezban Esen Karaca
    Bas, Murat
    Alan, Eyup Hakan
    Cagin, Yasir Furkan
    NUTRIENTS, 2024, 16 (10)
  • [28] Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis
    Danese, S.
    Siegel, C. A.
    Peyrin-Biroulet, L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (10) : 1095 - 1103
  • [29] Efficacy and safety of fecal microbiota transplantation via colonoscopy as add-on therapy in patients with mild-to-moderate ulcerative colitis: A randomized clinical trial
    Tkach, Sergii
    Dorofeyev, Andrii
    Kuzenko, Iurii
    Falalyeyeva, Tetyana
    Tsyryuk, Olena
    Kovalchuk, Oleksandr
    Kobyliak, Nazarii
    Abenavoli, Ludovico
    Boccuto, Luigi
    FRONTIERS IN MEDICINE, 2023, 9
  • [30] A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis
    Danese, Silvio
    Hart, Ailsa
    Dignass, Axel
    Fiorino, Gionata
    Louis, Edouard
    Bonovas, Stefanos
    D'Haens, Geert
    Dotan, Iris
    Rogler, Gerhard
    Paridaens, Kristine
    Peyrin-Biroulet, Laurent
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (09) : 1171 - 1182